Tratamientos para MOGAD
Virtual: GlobalÚnase a nosotros el 3 de febrero para una presentación en vivo y una discusión sobre las opciones de tratamiento para pacientes de MOGAD en América Latina. Para registrarse, […]
Únase a nosotros el 3 de febrero para una presentación en vivo y una discusión sobre las opciones de tratamiento para pacientes de MOGAD en América Latina. Para registrarse, […]
Join us on December 20th for TSF's final webinar of 2024: Managing Incontinence with Neuroimmune Disorders featuring Dr. Raveen Syan, Urologist and Assistant Professor of Clinical Urology at The University […]
Les troubles du sommeil sont courants dans les maladies neurologiques. La NMO et la MOGAD ne font pas exception. Que ce soit les troubles de l'endormissement, les réveils, le sommeil […]
TSF lo invita a unirse a nuestro próximo seminario web en español sobre MOGAD y la importancia de la participación de los pacientes en los ensayos clínicos. Nos sentimos honrados de contar con el Dr. José Flores de México y la Dra. Lucienne Costa Frossard França de España. ¡Esperamos que se una a nosotros en […]
Les résultats sont là ! Vous avez peut-être participé à l'enquête réalisée par Alexion en partenariat avec The Sumaira Foundation France intitulée "Vécu, besoins et attentes des patient(e)s atteint(e)s de NMOSD". En compagnie du Docteur Livia Lanotte, neurologue et présidente du réseau Alsacep, et Bérengère, ambassadrice TSF, nous reviendrons sur les résultats et les enseignements […]
कृपया 23 नवम्बर को सुबह 9 बजे IST पर हमारे विशेष वेबिनार में सम्मिलित हों, जिसमें डॉ. पार्थवी रावत द्वारा डिमायेलिनेटिंग बीमारियों से प्रभावित रोगियों और उनके परिवारों को शिक्षित और सहायता प्रदान करने हेतु बहुमूल्य जानकारी और विशेषज्ञ मार्गदर्शन दिया जाएगा। लाइव वेबिनार में शामिल होने वाले प्रतिभागियों को डॉ. रावत से सीधे प्रश्न […]
TSF is pleased to provide the Iranian neurology community around the globe with another lecture and case discussion: Imaging Features of MOGAD & NMOSD led by Dr. Eoin Flanagan, Professor of Neurology, Chair, Division of Multiple Sclerosis and Autoimmune Neurology, Program Director, Autoimmune Neurology Fellowship, Consultant, Departments of Neurology & Laboratory Medicine & Pathology at […]
TSF is pleased to provide the Iranian neurology community around the globe with another lecture and case discussion: Recent Findings on Retinal Changes in AQP4-NMOSD, MOGAD & DS cases led by Dr. Frederike Cosima Oertel, neuroimmunologist and NMOSD/MOGAD expert from Charité-Universitätsmedizin Berlin, Germany. We invite clinicians & researchers from all over the world to join […]
TSF is pleased to provide the Iranian neurology community around the globe with another lecture and case discussion: NMOSD Treatments led by Prof. Romain Marignier, neuroimmunologist and global NMOSD/MOGAD expert. […]
Are you a teen or young adult affected by rare neuroimmune disorders such as NMOSD or MOGAD? All are welcome between the ages of 13-25. The Human Collective Project (HCP) […]
TSF is pleased to provide the Iranian neurology community around the globe with another lecture and case discussion: Treatment Strategy for MOGAD: Acute & Maintenance Therapy led by Dr. Sara Mariotto, neuroimmunologist and global NMOSD/MOGAD expert. We invite clinicians & researchers from all over the world to join this important discussion. This series is being […]
In 2014, there were 0 FDA-approved therapies for patients living with neuromyelitis optica spectrum disorder (NMOSD). In 2024, there are 4 efficacious, FDA-approved therapies available for patients living with NMOSD. You're invited to "Approved NMOSD Therapies" a live webinar during which Dr. Sean Pittock* of the Mayo Clinic will provide overviews (pharmacology, drug delivery method, […]